Are high-care nursing home residents at greater risk of unplanned hospital admission than other elderly patients when exposed to Beers potentially inappropriate medications?

Geriatrics and Gerontology International

Volumn 14, Issue 4, 2014, Pages 934-941

  Price, Sylvie D ^a   Holman, C D'Arcy J ^a   Sanfilippo, Frank M ^a   Emery, Jon D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Aged; Hospitalization; Inappropriate prescribing; Nursing homes; Pharmacoepidemiology

Indexed keywords

AGED; ARTICLE; AUSTRALIAN; BEER; CONTROLLED STUDY; FEMALE; GERIATRIC CARE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; MALE; NURSING CARE; NURSING HOME PATIENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STUDY DESIGN; AUSTRALIA; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; INCIDENCE; NURSING HOME; PROCEDURES; RETROSPECTIVE STUDY; RISK; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; INCIDENCE; MALE; NURSING HOMES; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WESTERN AUSTRALIA;

EID: 84931835605     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12200     Document Type: Article

References (31)

1. Boparai MK, Korc-Grodzicki B. Prescribing for older adults. Mt Sinai J Med 2011; 78: 613-626.
2. Wynne HA, Blagburn J. Drug treatment in an ageing population: practical implications. Maturitas 2010; 66: 246-250.
3. Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008; 64: 183-199.
4. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for potentially inappropriate medication use in older adults - results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
5. Duckett SJ. Drug policy down under: Australia's Pharmaceutical Benefits Scheme. Health Care Financ Rev 2004; 25: 55-67.
6. Lopert R. Evidence-based decision-making within Australia's Pharmaceutical Benefits Scheme. Issue Brief (Commonw Fund) 2009; 60: 1-13.
7. Harris MG, Harris RD. The Australian health system: continuity and change. J Health Hum Serv Adm 1998; 20: 442-467.
8. Department of Health and Ageing. Medicare Benefits Schedule Book. Canberra: Australian Government, 2008.
9. Australian Institute of Health and Welfare. Residential Aged Care in Australia 2007-08: A Statistical Overview. Aged Care Statistic Series 28. Cat. No. AGE 58. Canberra: AIHW, 2009; 138-141.
10. Holman CDJ, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999; 23: 453-459.
11. Department of Health and Ageing. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. Canberra: Australian Government, 1991-2007.
12. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2007. Oslo: WHO, 2006.
13. Britt H, Miller G, Bayram C. The quality of data on general practice - a discussion of BEACH reliability and validity. Aust Fam Physician 2007; 36: 36-40.
14. MIMS Australia. MIMS Online [online]. St Leonards, NSW: MIMS Australia; 2008 [Cited 2008]. Available from URL: https://www.mimsonline.com.au/Search/Search.aspx.
15. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2008. Oslo: WHO, 2007.
16. Greenblatt DJ. Elimination half-life of drugs: value and limitations. Annu Rev Med 1985; 36: 421-427.
17. Birkett DJ. Pharmacokinetics made easy 3: half-life. Aust Prescriber 1988; 11: 57-59.
18. Suissa S. The case-time-control design. Epidemiology 1995; 6: 248-253.
19. Suissa S. The case-time-control design: further assumptions and conditions. Epidemiology 1998; 9: 441-445.
20. Quan H, Sundararajan V, Halfon P etal. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139.
21. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988; 128: 1185-1197.
22. Greenland S. Applications of stratified analysis methods. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2008; 283-302.
23. Greenland S, Rothman KJ, Lash TL. Measures of effect and measures of association. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2008; 51-70.
24. Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother 2010; 8: 562-570.
25. Lin HY, Liao CC, Cheng SH, Wang PC, Hsueh YS. Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases - experience in a Taiwanese medical setting. Drugs Aging 2008; 25: 49-59.
26. Akazawa M, Imai H, Igarashi A, Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 2010; 8: 146-160.
27. Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees - analysis of a US retiree health claims database. Drugs Aging 2010; 27: 407-415.
28. Department of Health and Ageing. Australian Statistics on Medicines 2004-05. Canberra: Australian Government, 2007.
29. White E, Armstrong BK, Saracci R. Principles of Exposure Measurement in Epidemiology: Collecting, Evaluating, and Improving Measures of Disease Risk Factors, 2nd edn. New York, NY: Oxford University Press Inc, 2008; 65-95.
30. Greenland S. Confounding and exposure trends in case crossover and case time-control designs. Epidemiology 1996; 7: 231-239.
31. Price SD, Holman CDJ, Sanfilippo FM, Emery JD. Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly. Pharmacoepidemiol Drug Saf 2013; 22: 1159-1170.